BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21245)

  • 21. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of central beta-adrenergic receptors by tazolol (1-isopropylamino-3-(2-thiazoloxy)-2-propanol).
    Skolnick P; Stalvey LP; Daly JW
    Life Sci; 1977 Dec; 21(11):1655-63. PubMed ID: 23478
    [No Abstract]   [Full Text] [Related]  

  • 23. Demonstration of the beta 2-adrenoceptor intrinsic efficacy of AY-28,925 using the PGF2 alpha-contracted guinea-pig trachea.
    Heaslip RJ; Giesa FR; Rimele TJ; Grimes D
    Eur J Pharmacol; 1987 Jun; 137(2-3):179-84. PubMed ID: 2886349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations.
    Mian MA; Malta E; Raper C
    J Pharm Pharmacol; 1984 Oct; 36(10):698-9. PubMed ID: 6150092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hexoprenaline: beta-adrenoreceptor selectivity in isolated tissues from the guinea-pig.
    O'Donnell SR; Wanstall JC
    Clin Exp Pharmacol Physiol; 1975; 2(6):541-7. PubMed ID: 207477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta 2-adrenoceptor selectivity in four series of beta-adrenoceptor agonists.
    Johansson LH; Persson H; Rosengren E
    Eur J Pharmacol; 1986 Oct; 130(1-2):97-103. PubMed ID: 2877893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
    Kenakin TP
    J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species difference in the beta1/beta2-adrenoceptor selectivity of SM220CL in the cat and guinea-pig.
    Bohmer K; Raper C
    Clin Exp Pharmacol Physiol; 1977; 4(4):349-58. PubMed ID: 198170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of interactions of R(+)- and S(-)-isomers of beta-adrenergic partial agonists, befunolol and carteolol, with high affinity site of beta-adrenoceptors in the microsomal fractions from guinea-pig ciliary body, right atria and trachea.
    Koike K; Horinouchi T; Takayanagi I
    Gen Pharmacol; 1994 Nov; 25(7):1477-81. PubMed ID: 7896063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.
    Manara L; Badone D; Baroni M; Boccardi G; Cecchi R; Croci T; Giudice A; Guzzi U; Landi M; Le Fur G
    Br J Pharmacol; 1996 Feb; 117(3):435-442. PubMed ID: 8821531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro assessment of the selectivities of various beta-adrenergic blocking agents.
    Dreyer AC; Offermeier J
    Life Sci; 1980 Dec; 27(22):2087-92. PubMed ID: 6111008
    [No Abstract]   [Full Text] [Related]  

  • 33. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
    Strosberg AM
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
    Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
    Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the activities of the beta-adrenoceptor agonists MJ9184-1 AND (--)-ISOPRENALINE IN GUINEA-PIG AND CAT PREPARATIONS.
    Davey T; Malta E; Raper C
    Clin Exp Pharmacol Physiol; 1974; 1(1):43-52. PubMed ID: 4156198
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-adrenoceptor selectivity of dobutamine: in vivo and in vitro studies.
    Maccarrone C; Malta E; Raper C
    J Cardiovasc Pharmacol; 1984; 6(1):132-41. PubMed ID: 6199596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of the conformational requirements for direct adrenergic stimulation.
    Gray AP; Reit E; Ackerly JA; Hava M
    J Med Chem; 1973 Sep; 16(9):1023-7. PubMed ID: 4147657
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence from agonist and antagonist studies to suggest that the beta1-adrenoceptors subserving the positive inotropic and chronotropic responses of the heart do not belong to two separate subgroups.
    Lumley P; Broadley KJ
    J Pharm Pharmacol; 1977 Oct; 29(10):598-604. PubMed ID: 21238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.